BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30293398)

  • 1. [Chinese expert consensus on the clinical diagnosis and treatment of advanced breast carcinoma(2018)].
    Chinese Anti-Cancer Association, Committee of Breast Cancer Society
    Zhonghua Zhong Liu Za Zhi; 2018 Sep; 40(9):703-713. PubMed ID: 30293398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chinese expert consensus on the clinical diagnosis and treatment of advanced breast cancer (2018).
    Xu B; Hu X; Feng J; Geng C; Jin F; Li H; Li M; Li Q; Liao N; Liu D; Liu J; Liu Q; Lu J; Liu Z; Ma F; Ouyang Q; Pan Y; Shen K; Sun T; Teng Y; Tong Z; Wang B; Wang H; Wang S; Wang S; Wang T; Wang X; Wang X; Wang Y; Wang Z; Wu J; Yan M; Yang J; Yin Y; Yuan P; Zhang J; Zhang P; Zhang Q; Zheng H
    Cancer; 2020 Aug; 126 Suppl 16():3867-3882. PubMed ID: 32710660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Guidelines for clinical diagnosis and treatment of advanced breast cancer in China (2020 Edition)].
    ; ;
    Zhonghua Zhong Liu Za Zhi; 2020 Oct; 42(10):781-797. PubMed ID: 33113619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Guidelines for clinical diagnosis and treatment of advanced breast cancer in China (2022 edition)].
    ; ;
    Zhonghua Zhong Liu Za Zhi; 2022 Dec; 44(12):1262-1287. PubMed ID: 36575780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Consensus of Chinese experts on hot issues in genetic testing of advanced breast cancer (2021 edition)].
    ;
    Zhonghua Zhong Liu Za Zhi; 2022 Jan; 44(1):60-67. PubMed ID: 35073649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
    Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
    J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival.
    Cance WG; Carey LA; Calvo BF; Sartor C; Sawyer L; Moore DT; Rosenman J; Ollila DW; Graham M
    Ann Surg; 2002 Sep; 236(3):295-302; discussion 302-3. PubMed ID: 12192316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
    Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
    Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Guidelines for clinical application of platinum drugs in breast cancer (2023 edition)].
    Breast Cancer Group, Branch of Oncologist, Chinese Medical Doctor Association
    Zhonghua Zhong Liu Za Zhi; 2023 Dec; 45(12):1018-1031. PubMed ID: 38110310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Locoregional recurrence of breast cancer: a retrospective comparison of treatment methods.
    Skowronek J; Piotrowski T
    Neoplasma; 2002; 49(6):426-31. PubMed ID: 12584593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].
    Zhang P; Xu BH; Ma F; Li Q; Yuan P; Wang JY; Zhang P
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):381-4. PubMed ID: 21875471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic treatment with capecitabine as maintenance therapy in patients with recurring or metastatic breast cancer: experience in the Oncology Hospital, National Medical Center Siglo XXI, Mexican Social Security Institute.
    Segura-González M; Quintana-Quintana M
    Med Oncol; 2015 Apr; 32(4):93. PubMed ID: 25720523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological Features and Prognosis of Metaplastic Breast Carcinoma: Experience of a Major Chinese Cancer Center.
    Zhang Y; Lv F; Yang Y; Qian X; Lang R; Fan Y; Liu F; Li Y; Li S; Shen B; Pringle GA; Zhang X; Fu L; Guo X
    PLoS One; 2015; 10(6):e0131409. PubMed ID: 26115045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expert consensus on the clinical application of platinums in advanced breast cancer (2020 version)].
    Breast Cancer Group, Branch of Oncologist, Chinese Medical Doctor Association
    Zhonghua Zhong Liu Za Zhi; 2021 Feb; 43(2):167-175. PubMed ID: 33601480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of anti-HER2 blockage therapy may improve survival in HER2 positive metastatic breast carcinoma patients.
    Arslan UY; Turker I; Aksoy S; Oksuzoglu B; Helvaci K; Yildirim Ozdemir N; Uyeturk U; Uysal Sonmez O; Budakoglu B; Zengin N
    J BUON; 2013; 18(3):585-93. PubMed ID: 24065468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus: 2016 edition.
    Cheng S; Chen M; Cai J;
    Oncotarget; 2017 Jan; 8(5):8867-8876. PubMed ID: 27780939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory component: a worsening factor in locally advanced breast cancer treated by radiotherapy and systemic therapy.
    Guedea F; Biete A; Ojeda B; Alonso C; Craven-Bartle J
    Tumori; 1991 Aug; 77(4):331-5. PubMed ID: 1746055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase 2, multicenter, single-arm study of eribulin mesylate with trastuzumab as first-line therapy for locally recurrent or metastatic HER2-positive breast cancer.
    Wilks S; Puhalla S; O'Shaughnessy J; Schwartzberg L; Berrak E; Song J; Cox D; Vahdat L
    Clin Breast Cancer; 2014 Dec; 14(6):405-12. PubMed ID: 25024001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
    Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA
    Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.